Future of Biomanufacturing: Why Single-Use Bioreactors Are Transforming the Biotech Landscape
In the fast-evolving world of biotechnology, flexibility and efficiency are everything. As biopharma companies race to develop new vaccines, biosimilars, and cell-based therapies, they need manufacturing systems that can keep pace with innovation. That’s where single-use bioreactors (SUBs) are changing the game — offering a faster, cleaner, and more sustainable way to produce biologics at scale.
According...
Single-Use Bioreactors: Powering the Growth of the Biologics Industry
The biologics industry is at the forefront of medical innovation, driving breakthroughs in vaccines, monoclonal antibodies, cell and gene therapies, and recombinant proteins. As demand for biologics continues to surge, the need for flexible, scalable, and cost-efficient manufacturing systems has become more pressing than ever. Enter the single-use bioreactor (SUB) — a technology that is...